In a rare move, the Justice Department on Tuesday announced that it had charged a former vice president and top lawyer for the British drug giant Glaxosmithkline with making false statements and obstructing a federal investigation into illegal marketing of the Antidepressant Wellbutrin for weight loss.
Executive is charged in drug fraud.